Novo Shares Drop After Trump Promises “Much Lower” Ozempic Prices Novo Nordisk A/S shares in Copenhagen appear to be experiencing yet another dead cat bounce following last month’s surge. That’s because President Trump told reporters late Thursday that GLP-1 drugs like Novo’s Ozempic, which currently costs about $1,000 per month, could soon cost “$150 out of pocket.” Bad news for Goldman analysts, who have been Novo’s ‘super bulls’ – but for those trying to catch a bottom in the stock, there may still be more downside ahead. Trump told reporters the cost of Ozempic will soon be “much lower,” adding, “Those are going… — Continue at ZeroHedge News : Read More
